ClearPoint Neuro (CLPT) Gross Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 502.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 502.00 |
| Dec 31, 2025 | -354.00 |
| Sep 30, 2025 | -829.00 |
| Jun 30, 2025 | -230.00 |
| Mar 31, 2025 | -374.00 |
| Dec 31, 2024 | -1,308.00 |
| Sep 30, 2024 | -681.00 |
| Jun 30, 2024 | -315.00 |
| Mar 31, 2024 | -563.00 |
| Dec 31, 2023 | -1,220.00 |
| Sep 30, 2023 | -1,754.00 |
| Jun 30, 2023 | -1,510.00 |
| Mar 31, 2023 | -1,115.00 |
| Dec 31, 2022 | -4,883.00 |
| Sep 30, 2022 | 781.00 |
| Jun 30, 2022 | 213.00 |
| Mar 31, 2022 | 8.00 |
| Dec 31, 2021 | 5,290.00 |
| Sep 30, 2021 | -290.00 |
| Jun 30, 2021 | 2,289.00 |
| Mar 31, 2021 | 2,414.00 |
| Sep 30, 2019 | 998.00 |
| Jun 30, 2019 | 932.00 |
| Mar 31, 2019 | 1,513.00 |
| Sep 30, 2018 | 1,572.00 |
| Jun 30, 2018 | 129,360.00 |
| Mar 31, 2018 | -1,980.00 |
| Sep 30, 2016 | 124,166.00 |
| Jun 30, 2016 | 1,062.00 |
| Mar 31, 2016 | 9,603.00 |
| Sep 30, 2015 | -3,456.00 |
| Jun 30, 2015 | -123,978.00 |
| Mar 31, 2015 | 5,438.00 |
| Dec 31, 2014 | -178,331.00 |
| Sep 30, 2014 | -2,701.00 |
| Jun 30, 2014 | -827.00 |
| Mar 31, 2014 | -3,195.00 |